Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
about
Immunoregulation in human American leishmaniasis: balancing pathology and protectionCD3+CD4negCD8neg (double negative) T lymphocytes and NKT cells as the main cytotoxic-related-CD107a+ cells in lesions of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis.Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing alpha-gal epitopesT-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy.Trypanosoma cruzi-induced activation of functionally distinct αβ and γδ CD4- CD8- T cells in individuals with polar forms of Chagas' disease.Up-regulation of Th1-type responses in mucosal leishmaniasis patientsDual immune modulatory effect of vitamin A in human visceral leishmaniasis.Immunoregulatory and Effector Activities in Human Cutaneous and Mucosal Leishmaniasis: Understanding Mechanisms of Pathology.Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathologyDNA vaccine using Mycobacterium bovis Ag85B antigen induces partial protection against experimental infection in BALB/c mice.Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasis.Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection.Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alpha beta and gamma delta T cells from human patients with cutaneous leishmaniasis.Matrix metalloproteinase 9 production by monocytes is enhanced by TNF and participates in the pathology of human cutaneous Leishmaniasis.The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy.HIV-1 vaccines and co-infection.CD8(+) T cells in leishmania infections: friends or foes?Protein biomarkers discriminate Leishmania major-infected and non-infected individuals in areas endemic for cutaneous leishmaniasis.Characterization of Neutrophil Function in Human Cutaneous Leishmaniasis Caused by Leishmania braziliensisThe immunobiology of Leishmania braziliensis infection.Leishmaniavirus-Dependent Metastatic Leishmaniasis Is Prevented by Blocking IL-17A.Cytokines and microbicidal molecules regulated by IL-32 in THP-1-derived human macrophages infected with New World Leishmania species.Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathologyDifferential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis.Association of HLA class I and II genes with cutaneous leishmaniasis: a case control study from Sri Lanka and a systematic review.Ex vivo restimulation of human PBMC expands a CD3+CD4-CD8- γδ+ T cell population that can confound the evaluation of CD4 and CD8 T cell responses to vaccination.Interleukin 17 production among patients with American cutaneous leishmaniasis.Characterization of regulatory T cell (Treg) function in patients infected with Leishmania braziliensis.Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature.The Role of CD4 and CD8 T Cells in Human Cutaneous Leishmaniasis.Comparison of Th1 and Th2 responses in non-healing and healing patients with cutaneous leishmaniasis.Immunoregulatory profile of monocytes from cutaneous leishmaniasis patients and association with lesion size.Antigenic fractions of Leishmania (Viannia) braziliensis: the immune response characterization of patients at the initial phase of disease.LACK-specific CD4(+) T cells that induce gamma interferon production in patients with localized cutaneous leishmaniasis during an early stage of infection.Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity.Leishmania major large RAB GTPase is highly immunogenic in individuals immune to cutaneous and visceral leishmaniasis.Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis.Immunologic Markers of Protection in Leishmania (Viannia) braziliensis Infection: A 5-Year Cohort Study
P2860
Q26850280-C78A3BCF-4C0D-4E78-B712-B1FB01C45B3CQ33634962-18F76746-D676-46BD-9927-F5651BC339ECQ33725704-FF9D59BF-2BFB-4387-8490-B8FCA7DCB727Q33837215-B4F6CF9D-D0F0-43C2-AABD-284259640C03Q33942376-0E90D4F8-4461-49BE-958C-E47317E2F065Q34177376-73E98607-8221-4884-B99D-630BC5126FDCQ34259236-4F68C810-33F7-4792-9834-5C0D81CC39C1Q34275996-B66B185A-7F21-4DDC-91B5-C71A268E0F97Q34624834-47A90471-B030-4213-9E62-998CAE4B264DQ34717421-A8BCE4F7-BA8C-4337-8DDF-6C93CF9B1CFAQ34975023-ABC3D546-A6CE-4E74-85F8-592FEF5C4008Q35037274-17524FFF-CACE-4DD6-B72B-F6148CA7606CQ35098224-7C306420-2C1A-481A-9452-6B82967027C0Q35106404-6AD7686F-CCC8-4CB1-8189-34211AAE82EDQ35217598-3C42A7D3-8934-4D5F-B5D7-7696F89C2623Q35418042-A070354C-BCBF-43E1-8444-0BB77E25434BQ35814748-B0DF23AC-8A04-4C65-9B3C-ED5213D1682CQ35873784-45CABB42-6272-48E6-B624-C7A7CF5D23FAQ35927465-EB2CB59F-C328-4501-AE61-E6F144E5D51BQ35968320-F72494F2-2E01-4912-8B4D-4A6C6A17A7ABQ36014374-05B5883C-C561-42F2-A71C-D1A9D80538ADQ36017212-649B6880-8B26-462C-8E00-1B21DD3ACFDEQ36141241-59FEFF3D-4BCE-4F0F-8860-4F5AAA201A05Q36291428-991CAB65-BCB5-403D-B0E4-849F2E036171Q36617322-0AE5F860-58AD-49CD-B79C-6E6641B6C7C2Q36995009-0D1BED9C-3BF1-42D9-AB1B-8F9010D92C0DQ37006391-104EFFAD-4068-4664-B5BF-2B3B8A44A66BQ37162910-5FC1106B-2624-44BD-976E-4AC196429322Q37319920-52C80268-B318-45DB-ADD2-B1066D841F5DQ37355885-1B40CC48-2C08-4D9A-8EC6-F624BE9FA105Q37773297-1B1926FB-3D23-47B8-8151-38439E4D2660Q38261036-EC1FB211-3052-48DC-9139-1DCEF0DD4276Q38533597-6A9C008B-42A2-40B6-AC3D-B6B2176E3F4EQ39560197-B74F0D83-89B2-45D4-A295-84FE01F5376FQ39644235-9FE19F0B-6904-4EB7-A251-A1EFD0040B3DQ39655332-36935B0F-9F64-4439-BA37-645D62DB4591Q40014457-3514D641-A1BC-45C1-B50A-D4A38EE8C0C1Q40239822-35EC0ECC-AB5A-4914-8684-4873B081BE24Q40380946-3133060A-7922-41BF-80F3-7B9081E9CBC8Q40670558-1204A91B-1E41-4C10-9778-67748229FEB8
P2860
Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Flow cytometric determination ...... human cutaneous leishmaniasis.
@en
Flow cytometric determination ...... human cutaneous leishmaniasis.
@nl
type
label
Flow cytometric determination ...... human cutaneous leishmaniasis.
@en
Flow cytometric determination ...... human cutaneous leishmaniasis.
@nl
prefLabel
Flow cytometric determination ...... human cutaneous leishmaniasis.
@en
Flow cytometric determination ...... human cutaneous leishmaniasis.
@nl
P2093
P2860
P1476
Flow cytometric determination ...... human cutaneous leishmaniasis
@en
P2093
Almeida RP
Bottrel RL
Carvalho E
Locksley R
Martins FA
P2860
P304
P356
10.1128/IAI.69.5.3232-3239.2001
P407
P577
2001-05-01T00:00:00Z